Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 févr. 2018 09h00 HE | Source: Precipio, Inc.

Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter

NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited revenues for the 4th quarter of 2017 of approximately...
06 févr. 2018 08h37 HE | Source: Precipio, Inc.

Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale

NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™...
22 janv. 2018 08h27 HE | Source: Precipio, Inc.

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...
16 janv. 2018 08h27 HE | Source: Precipio, Inc.

Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion

NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO) has appointed Douglas Sites to the new position of Vice President of Sales where he will...
10 janv. 2018 08h27 HE | Source: Precipio, Inc.

Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

NEW HAVEN, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced preliminary data from an ongoing study on the impact of academic...
20 déc. 2017 08h00 HE | Source: Precipio, Inc.

Precipio Launches Its Second New ICE-COLD PCR™ Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify...
14 déc. 2017 08h00 HE | Source: Precipio, Inc.

Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media

NEW HAVEN, Conn., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced the recent filing of a patent application for IV-Cell, a novel media (reagent) developed by Precipio...
20 nov. 2017 16h05 HE | Source: Precipio, Inc.

Precipio Announces Third Quarter 2017 Financial Results and Provides Corporate Update

NEW HAVEN, Conn., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced financial results for the third quarter ended September 30, 2017 and provided an update on corporate...
16 nov. 2017 16h15 HE | Source: Precipio, Inc.

Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

NEW HAVEN, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced it will issue financial results for the Third Quarter ended September 30, 2017 and provide an update...
14 nov. 2017 16h15 HE | Source: Precipio, Inc.

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli...

Page précédente